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a  b  s  t  r  a  c  t
Evidence  of  a high  or increasing  incidence  of childhood  onset  bipolar  disorder  in  the  United  States  (US)
has been  viewed  skeptically.  Here  we review  evidence  that  childhood  onsets  of  bipolar  disorder  are  more
common  in the US  than  in  Europe,  treatment  delays  are  longer,  and  illness  course  is more  adverse  and
difﬁcult.  Epidemiological  data  and  studies  of  offspring  at high  risk  also  support  these  ﬁndings.
In our  cohort  of outpatients  with  bipolar  disorder,  two of  the  major  vulnerability  factors  for  early  onset
− genetics  and  environmental  adversity  in  childhood  −  were  also  greater  in  the  US  than  in Europe.  An
increased  familial  loading  for multiple  psychiatric  disorders  was  apparent  in  4 generations  of  the  family






Since  both  early  onset  and  treatment  delay  are  risk factors  for a poor  outcome  in adulthood,  new  clinical,
research,  and  public  health  initiatives  are  needed  to begin  to address  and  ameliorate  this  ongoing  and
potentially  devastating  clinical  situation.
© 2017  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).rimary and secondary prevention
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. Introduction
A higher incidence of childhood onset bipolar disorder in the US
as most often been attributed to a variety of factors suggesting
hat it is artifactual rather than real. These factors have included: a
roadening of the diagnosis, diagnostic differences between coun-
ries, over diagnosis, and artiﬁcial coding related to reimbursement.
his skeptical view of the data has resulted in neglect of the magni-
ude of the problem in terms of clinical therapeutics, public health
ractices, and a treatment research agenda.
In this manuscript we review the evidence that much of the
igh incidence is very likely real and deserving of greater and mul-
ifaceted attention. The evidence reviewed includes: comparative
tudies of US versus European populations of patients with bipo-
ar disorder, epidemiological studies, clinical samples, prospective
ollow up studies of children with a bipolar diagnosis, and stud-
es of high risk offspring of a parent with bipolar disorder that
ere carried out in the US compared to non-US sites. In addi-
ion, potential reasons for the higher incidence in the US than
n Europe are explored and include evidence of greater genetic
ulnerability; more childhood adversity mediating psychosocial
tress vulnerability; and other potential factors such as diet and
igher rates of obesity with associated inﬂammation. Other pos-
ible contributors to the increased presence of childhood onset
ipolar disorder include cohort (year of birth) and anticipation
generational) effects.
Assuming that this accumulation of evidence supports the view
hat many aspects of bipolar disorder present a greater problem in
he US than in many other countries, several suggestions for better
ddressing this situation are offered. These are important to con-
ider as more than a dozen studies (as cited below) suggest that
hildhood onset bipolar disorder runs a more difﬁcult course and
as a poorer outcome than adult onset illness. Multiple approaches
re likely to be necessary to address the magnitude of the problem
nd its long-term consequences. A very extensive revision of the
urrent treatment and research agenda will likely be necessary to
egin to reverse some of the multigenerational trends for greater
llness adversity in the US compared to Europe.
. Types of studies and data
.1. Comparative studies involving patients inside and outside of
he US
Four studies directly compared patients from the US to those in
urope or Argentina.
. In the Stanley Foundation Treatment Outcome Network (SFBN)
more than 900 outpatients were recruited and followed prospec-
tively with cross sectional and daily life chart ratings from 1995
to 2002. About 75% were bipolar I and 25% bipolar II based on
SCID diagnoses (Post et al., 2014a). They came from four sites in
the US (Los Angeles, Dallas, Cincinnati, and Bethesda), and from . . .  . . .  . . .  . .  .  . . . .  . . .  . .  . . .  . . . . .  . . . . .  .  . .  .  . . . .  .  . .  . . .  .  .  .  . .  . . . . .  . . . . .  .  .  .  .  . .  .  .  .  .  .  . 211
three sites in Europe (Utrecht, the Netherlands, and Freiberg and
Munich, Germany; abbreviated here as Europe). In the US versus
Europe, we found onsets in childhood (before age 13) in 31.1% vs
5.6%; in adolescence (13–18) 38.1% vs. 26.6%; in young adulthood
(19–29) 19.8% vs 42.2%; and in older adulthood (30 and greater)
11.0% vs 23.7%. Thus, some two  thirds (69.2%) of the onsets in
US adult patients with bipolar disorder started in childhood or
adolescence, and only one third (32.2%) in Europe. Regarding
concerns that our US sample might be non-representative, the
percentage of early onset was virtually identical to that seen
in the STEP-BD cohort (Perlis et al., 2004) where recruitment
was from entirely different cities and academic institutions in
the US than those in the SFBN (now referred to as the Bipolar
Collaborative Network or BCN)
2. Bellivier et al. (2014) compared patients with bipolar disorder in
the Pittsburgh case registry in the US to those from 10 different
European countries. Using an admixture analysis they found a
distinct increase in the youngest onset patients in the US (63%)
compared to 25% in Europe, such that the average age of onset
difference in this subgroup was 4.5 years.
3. Etain et al. (2012), using the same admixture analysis to deﬁne an
early onset subgroup, also found that 68% of the bipolar patients
in the US (from the Bipolar Phenome Database) belonged to this
group in contrast to only 42% of the patients from France who
were in this early onset subgroup.
4. Holtzman et al. (2015a) found a much earlier mean age of onset
of bipolar disorder in the US (17.9 ± 8.4 yrs.) compared to that in
Argentina (27.1 ± 11.4 years).
2.2. High risk offspring studies conducted in the US versus
elsewhere
A substantial series of studies have examined the incidence and
age of onset of bipolar disorder in the offspring of parents with
bipolar disorder. Compared to those conducted elsewhere, those
conducted in the US have seen more early onset bipolar disorder
in the offspring followed prospectively. Exact comparisons across
studies are not possible because of differences in the age range of
the offspring studied and duration of follow up. However, those in
the US report a percent incidence of bipolar disorder in the range
of 3% to 16% (Birmaher et al., 2009b; Chang et al., 2000; Henin
et al., 2005; Nurnberger et al., 2011; Singh et al., 2007; Zappitelli
et al., 2011). In contrast, Duffy et al. (2007) from Canada, Wals et al.
(2004) and Hillegers et al. (2005) from the Netherlands, Vandeleur
et al. (2012) from Switzerland, and Grigoroiu-Serbanescu et al.
(1989) from Romania, rarely saw bipolar onsets prior to late adoles-
cence or early adulthood. They tend to see a temporal evolution of
onsets ﬁrst of anxiety disorders in the youngest children, followed
by depressions, and only later bipolar disorder (Duffy et al., 2007,
2009; Hillegers et al., 2005)
Birmaher et al. (2010), while not making direct comparisons
with European offspring studies, reported that the US parents with
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tric comorbidities. These included an anxiety disorder in 72.5%, a
ubstance abuse disorder in 63.9%, disruptive behavioral disorder
n 36.9%, and ADHD in 27.5%. The high occurrence of these comor-
id illnesses in the US parents with bipolar disorder could account
or some of the US versus European offspring differences, as the
oading of psychopathology in the parent appears related to many
f the offspring illnesses.
Mesman et al. (2016) directly compared children of a bipolar
arent from the US with those from the Netherlands rated on the
ame interview instrument, the Schedule for Affective Disorders
nd Schizophrenia for School Age Children (K-SADS-PL). They also
valuated dimensional psychopathology by parental reports using
he Child Behavior Checklist (CBCL). They found more psychiatric
omorbidities in the offspring with mood disorders from the US
ersus the Dutch sample (80% versus 34%; OR: 7.84, p < 0.001),
ut not an earlier age of onset of bipolar disorder in that sam-
le. However, BP-NOS was highly prevalent in the US sample and
ot assessed in the Dutch sample, so that the lack of difference
n bipolar disorder or early onset should be viewed with cau-
ion. Surprisingly, there were no differences in the parent-reported
imensional psychopathy, such that they concluded that: “Cultural
nd methodological explanations for these ﬁndings warrant further
tudy.” Their caution is mirrored by the ﬁndings of many investi-
ators that cultural differences and other methodological factors
ould account for some regional diagnostic differences (Dubicka
t al., 2008; Jensen-Doss et al., 2014; Mackin et al., 2006; Mesman
t al., 2016; Rettew et al., 2009; Stoll et al., 1993).
In our cohort of patients with bipolar disorder, the offspring
ere not followed prospectively or formally diagnosed with sys-
ematic interviews. Nonetheless, the offspring of parents with
ipolar disorder from the US had signiﬁcantly (p < 0.001) more
epression, bipolar disorder, suicide attempts, alcohol abuse, and
other” illness that those from the Europeans (Post et al., 2016a).
verall, 46.3% of the offspring from the US had any diagnosis com-
ared to 16.1% in those from the Netherlands and Germany.
In a 7 year prospective follow up study with formal diagnostic
valuations, Axelson et al. (Axelson et al., 2015) found a simi-
ar ratio of illnesses, but much higher incidence, such that 74%
f the offspring of a US bipolar parent received a lifetime psy-
hiatric diagnosis compared to a still-striking incidence of 48%
n the community controls (also from the US). The incidences of
ost illnesses in the high risk offspring were strikingly higher than
he controls. This included: an anxiety disorder (39.9% vs 21.8%);
ajor depressive disorder (32.0% vs 14.9%); ADHD (30.7% vs 18.1%);
isruptive behavioral disorder (27.4% vs 15.3%); substance use dis-
rders (19.9% vs 10.1%); and any bipolar spectrum disorder, ie
P I, II, or NOS (19.2% vs 2.0%). Children initially diagnosed with
epression, a disruptive behavioral disorder, or subthreshold manic
ymptoms (ie those with only brief bursts of mania − what they
ave labeled bipolar not otherwise speciﬁed or BP-NOS) were the
nes most likely to convert to BP I or II upon follow up (Axelson
t al., 2015).
In a 20 year follow up of offspring of a parent with unipolar
epression in the US, Weissman et al. (2006) found that 83% had
cquired a psychiatric diagnosis, as had 56% of the community
ontrols. Rasic et al. (2014) in a meta-analysis found that lifetime
sychiatric diagnoses in offspring of a parent with depression or
ipolar disorder were higher than in controls and only slightly less
revalent than in those whose parent had schizophrenia. Bipolar
isorder also occurred in the offspring of parents with schizophre-
ia and unipolar depression, suggesting some non-speciﬁcity of
ulnerability to bipolar disorder in offspring from a parent with
ther illnesses beyond bipolar disorder. These data mirror those of
andeleur et al. (2012) which also showed a small percentage ofvioral Reviews 74 (2017) 204–213
bipolar spectrum disorders in offspring of parents with unipolar
disorder.
2.3. Epidemiological studies
Merikangas et al. (2010) reported that the incidence of a bipolar
spectrum disorder in the US was 2.2% among 13–18 year olds. In
their review of childhood onset bipolar disorder, Van Meter et al.
(2011) reported similar incidences among a wide range of coun-
tries. However, the majority of these surveys did not include a
BP-NOS category. When BP-NOS was  included in the assessment,
the US studies reported an average of about a 6.7% incidence, while
in non-US studies the incidence averaged about 2.4%. This differ-
ence is of some consequence since the youngest patients have a
high incidence of BP-NOS. Birmaher et al. (2009a) and Axelson et al.
(2015) report that about 30–50% of BP-NOS children convert to BP I
or BP II upon several years of follow up, and conversion is higher in
those with a positive family history of bipolar disorder. The BP-NOS
children were highly impaired and almost as severely ill as those
with BP I and BP II, and in fact took very much longer to achieve
mood stabilization (Birmaher et al., 2009a).
Merikangas et al. (2010) reported in adults a higher lifetime
prevalence of bipolar spectrum disorders in the US of 4.4% com-
pared to many other countries, including 2.3% in South American
countries such as Brazil and Colombia. Since approximately two
thirds of bipolar disorder in adults in the US begins in childhood
or adolescence (Perlis et al., 2004; Post et al., 2014a), and there is
considerable continuity of childhood with adult bipolar disorder
(Geller et al., 2008), one would infer that there had to be a higher
incidence in youngsters in the US than in many other countries.
Similarly, Blanco et al. (2008) in the US found 12-month prevalence
rates of bipolar disorder in 3.24% of college students age 19–25 and
even higher rates of 4.62% in non-college students of the same age.
Many of these would likely have had onsets even earlier in life.
Overall, about 46% of these students had one or more psychiatric
diagnoses, but only 25% were in any kind of treatment.
2.4. Long term prospective follow up of childhood onset bipolar
disorder
Prospective naturalistic follow up studies of childhood onset
illness are pertinent to the issue of US versus non-US incidence
from several different perspectives. All of the longitudinal stud-
ies of young children with bipolar disorder of which we  are aware
emanate from US sites (Birmaher et al., 2009a; DelBello et al., 2007;
Geller et al., 2008; Gitlin et al., 1995; Wozniak et al., 2011). In
general, these report a considerable continuity of illness, both in
terms of: a) a high level of diagnostic stability, and b) chronic per-
sistence of symptoms during about 2/3 of the time of follow up
(Geller et al., 2008). Birmaher et al. (2014) described four differ-
ent groups of trajectories of illness: 1) “predominantly euthymic”
(24.0%), 2) “moderately euthymic” (34.6%), 3) “ill with improv-
ing course”(19.1%), and 4) “predominantly ill”(22.3%).” Those in
the predominantly euthymic group 1 were characterized as being
older, less severely ill at baseline, less treated with stimulants and
antidepressants, and having less loading for a family history of
bipolar disorder or substance abuse. Those in the predominantly
ill group 4 showed essentially the opposite characteristics, includ-
ing early age of onset, more severe illness at baseline, abuse in
childhood, more parental illness and substance abuse, and lower
socioeconomic status.
However, even in those in the best functioning group 1, despite
being predominantly euthymic, “over 50% of the youths contin-
ued to experience new syndromal manic or depressive episodes,
indicating that they continued to have active, clinically meaning-
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hus, levels of severity of illness might vary over time, but the ill-
ess did not remit spontaneously, as was reported in the later onset
oung adults in the epidemiologically diagnosed subjects reported
y Cicero et al. (2009) as discussed below.
High rates of bipolar disorder in more recent outpatient vis-
ts (Moreno et al., 2007) and in hospitalized patients (Blader and
arlson, 2007) also speak to the substantial prevalence in the US
linical population, although reservations about the contribution of
ifferences in diagnostic practices in the US compared to elsewhere
re further discussed below
.5. Retrospective clinical studies and potential etiological
echanisms
Not all European countries report a dearth of childhood onset
ipolar disorder. Remarkable among these reporting childhood
nd adolescent onsets not dissimilar to that reported in the US
s Norway (which had 23% with childhood onsets in hospitalized
atients (Morken et al., 2009), and 6% in an epidemiological catch-
ent area study (Larsson et al., 2010). Soutullo et al. (2005) also
eported variable rates of childhood onset bipolar disorder across
ifferent countries.
A wide variation in age of onset in different cities and countries
hroughout the world was reported by Bauer et al. (2014). They
ound that cities with the highest degrees of solar insolation (angle
f the sunlight affecting its intensity) were the ones which had the
arliest ages of onset of bipolar disorder. While many of those cities
ith a high incidence of early onsets were in the US (such as Los
ngeles and San Francisco), other cities in the US (such as Miami,
rinceton, and Boston) had lower solar insolation measures and
ater ages of onset, making it difﬁcult to directly compare US and
on-US sites.
The increased levels of obesity in the US compared to Europe
Post et al., 2014a) and their potential relationship to increases
n inﬂammation (Goldstein and Young, 2013) also deserve further
xamination in relationship to early onset and a more difﬁcult
ourse of illness. Goldstein et al. (2008) reported that children
ith bipolar disorder age 7–17 were likely more obese than chil-
ren in the general population and obesity was more prominent
n the youngest patients. Obesity has also been linked to increases
n inﬂammation in the brain and periphery, and increased levels
f inﬂammatory markers have been reported in childhood onset
ipolar disorder (Goldstein and Young, 2013).
. Childhood onset bipolar disorder has a poorer prognosis
han adult onset illness
The literature is generally consistent in the view that early onset
llness has a more difﬁcult course into adult than adult onset illness
Bellivier et al., 2014; Birmaher et al., 2014; Carlson et al., 2002;
arter et al., 2003; Ernst and Goldberg, 2004; Etain et al., 2012;
oltzman et al., 2015b; Lish et al., 1994; Mick et al., 2003; Perlis
t al., 2009; Perlis et al., 2004; Post et al., 2010; Schurhoff et al.,
000). However, these studies are based either on prospective fol-
ow up studies of young children or retrospective studies in adults
ooking back to ages of onset in childhood.
In contrast, Cicero et al. (2009) in their analysis of two  large
pidemiological data sets found a peak 12 month incidence and
ifetime prevalence of bipolar disorder at ages of onset of 18–20
nd 21–24, but then a substantial drop off thereafter. Based on
hese data, they suggested that there might be a subgroup of these
merging adults with onsets of bipolar disorder that is associated
ith spontaneous remission. It is noteworthy that the two  studies
hey analyzed did not interview individuals under the age of 18,
o they could not examine the persistence of illness in those withvioral Reviews 74 (2017) 204–213 207
childhood and early adolescent onsets. In the retrospective stud-
ies of Post et al. (2010) and Holtzman et al. (2015b) children (<13)
had even poorer outcomes in adulthood than those with adolescent
onsets (<19).
Thus, the general ﬁndings in the multiple studies noted above
that those with childhood onsets have a more difﬁcult course and
outcome than those with adult onsets is not incompatible with
Cicero’s observations that there may  be spontaneous remissions in
some later onset patients (age 18–24) as diagnosed in the epidemi-
ological studies. Convergent with this viewpoint is the analysis of
Goldstein and Levitt, (2006) of the National Epidemiologic Survey
on Alcohol and Related Conditions which identiﬁed 1411 adults
with bipolar disorder where they found that non-remitting illness
was more likely in those with childhood onsets (<13 yrs) and these
children also experienced longer episodes and more antisocial per-
sonality and drug use disorders.
Several factors could contribute to the poor outcome of child-
hood onset illness. Studies have shown that an earlier age of onset is
associated with a longer delay to ﬁrst treatment of either depres-
sion or mania (Morken et al., 2009; Post et al., 2010; Suominen
et al., 2007; Wang et al., 2005). In our cohort of patients (average
age 40 at Network entry in 1995–2002), those who  reported the
onsets of bipolar disorder in childhood (< age 13) experienced an
average duration of delay to ﬁrst treatment of more than 15 years.
Those with adolescent onsets (< age 19) averaged more than a 10
years lag to ﬁrst treatment, while those with adult onsets averaged
3–5 years delay (Post et al., 2010). Lish et al. (1994) and Hirschfeld
et al. (2003) reported somewhat shorter delays to ﬁrst treatment
when they used an average duration of delay across their whole
patient cohort independent of the age of onset of bipolar disorder.
In a multiple regression, we  found that the duration of the delay
to ﬁrst treatment was  related to a poor prospective clinician-rated
outcome independent of that related to earlier age of onset. The
longer delays to ﬁrst treatment were associated with longer dura-
tion and severity of depression, more ultra-rapid cycling, and less
time euthymic in prospectively rated adults (Post et al., 2010).
However, two caveats about the duration of the treatment
delay are noteworthy. The delay data were based on retrospective
reports by adults at network entry in 1995–2002. For those report-
ing childhood onsets, the onsets and treatment delays represent
occurrences approximately 40 years ago when bipolar disorder in
children was rarely recognized. More recent data from a commu-
nity health center in the years 2000–2003 suggest that delay from
onset of illness to ﬁrst diagnosis (and treatment) may  have become
much shorter, although in a small subgroup (16.7%) of the indi-
viduals the delay was still longer than 10 years (Marchand et al.,
2006).
Thus, the bulk of retrospective data from multiple studies indi-
cate that childhood onset bipolar disorder has a difﬁcult outcome,
which to some extent is further exacerbated by delay to ﬁrst treat-
ment. The poor outcome of childhood onset illness may  reﬂect that
it is an inherently more severe illness than later onset illness.  . .
Childhood onset illness would be occurring in an immature and
developing nervous system, and the child would have the added
risks of loss of social and educational opportunities. Childhood
onsets also come with a considerable risk of later substance abuse,
which carries further difﬁculties for treatment and compliance.
Goldstein et al. (2013) reported a 32% rate of developing new onset
of substance abuse disorder in youth diagnosed with bipolar dis-
order after 2.7 years of follow up. Lin et al. (2006) suggested that
early onset bipolar disorder may  be a distinct subtype and that early
onset and substance abuse are genetically related. Further support-
ing the possibility that early onset is a separate genetic subtype
are the data of Preisig et al. (2016) indicating that compared to
adult onsets, early onset illness was more likely associated with
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arent. We  also found early onset bipolar disorder in the parent
onveyed increased risk of multiple illness in the offspring (Post
t al., 2016a).
. Vulnerability factors
.1. The US has more genetic/familial risk factors for childhood
nset bipolar disorder than the Europeans
When examining the amount of illness in the offspring of
atients in the US versus the Netherlands or Germany, we  looked
ackward 3 generations and also found each of these generations
ore ill than the Europeans. Compared to the Europeans, not only
ere our US adult patients more ill and had more poor prognosis
actors (including early onset bipolar disorder, adversity in child-
ood, anxiety disorder comorbidity, alcohol and substance abuse,
apid cycling and more with >20 prior episodes) (Post et al., 2014a),
ut their parents (i.e., offspring’s grandparents) and grandparents
i.e., offspring’s great-grandparents) had more illness as well (Post
t al., 2015a, 2016a; Post et al., 2015c). Compared to the Euro-
eans, these illnesses in the US relatives included more depression,
ipolar disorder, suicide attempts, alcohol abuse, substance abuse,
nd “other” illness. These grandparental and great-grandparental
llnesses tended to “breed true” in offspring illness and the total
urden of illness in these relatives also related to an earlier age
f onset of bipolar disorder in the patients and increased occur-
ence of bipolar disorder in the offspring (Post et al., 2016a,b). These
ata again suggest vulnerability to bipolar illness may  be derived
rom the genes not only related to bipolar disorder itself, but other
llnesses as well.
In summary, in spite of the possibility of different cultural biases
nd methodological differences inﬂuencing some of the family his-
ory data on bipolar disorder, there is still considerable evidence
f many other psychiatric illnesses occurring more frequently in 4
enerations of family members of patients from the US compared to
he Europeans. These preliminary ﬁndings require direct conﬁrma-
ion in properly controlled epidemiological studies, however. The
ndings of more familial loading for psychiatric illness in the US
re consistent with what would be expected from the substantial
ncidence of childhood onset bipolar illness in the US, as virtually
ll of the family studies of bipolar disorder indicate greater familial
oading in those with childhood compared to adult onsets (Pavuluri
t al., 2004).
Assuming the ﬁndings of increased familial loading in the US
ver multiple generations are replicated using other methodolo-
ies, the question arises as to how this situation may  have emerged.
igration of more people with traits for bipolar illness and other
isorders may  have occurred some generations ago. Another source
f genetic vulnerability is assortative mating (for example, where
ne parent with depression marries another depression). A large
tudy from Sweden ﬁnds evidence of strong assortative mating for
DHD and autistic spectrum, moderate but signiﬁcant assortative
ating for mood disorders, and no assortative mating for medi-
al disorders (Nordsletten et al., 2016). In our Network we  found
–3 times more assortative mating in patients from the US than
rom Europe (Post et al., 2014a,b). Moreover, the spouses of the US
atients had more illness than the spouses of the European patients.
hus, more assortative mating and marrying spouses with other
llnesses could contribute to an increased genetic loading because
f vulnerability carried by both parents (Gottesman et al., 2010;
apalme et al., 1997; Nordsletten et al., 2016).Another potential mechanism for increasing the gene pool for
ipolar disorder and related illness has been described by Comings
1996). He presented data that a shorter time between genera-
ions (having offspring at younger ages) in those at highest riskvioral Reviews 74 (2017) 204–213
for psychiatric illness could in a matter of just 3 or 4 generations
dramatically increase the frequency of risk genes in the general
population. In accord with this possibility, the US is ranked high
(46th) in having a young average age at ﬁrst birth of 25 years com-
pared to later ages at ﬁrst birth in most European countries, such
as 28.9 in Germany and Netherlands and 30 in the United Kingdom
and Switzerland.
4.2. Environmental stressors and childhood adversity are more
frequent in the US than in europe
Another major risk factor for early onset bipolar disorder is
adversity in childhood in the form of verbal, physical, or sexual
abuse (Brown et al., 2005; Garno et al., 2005; Leverich et al., 2007).
Compared to the Europeans, patients in our Network from the US
had signiﬁcantly more of each type of abuse (Post et al., 2013a).
More than 50% of those from the US experienced verbal abuse com-
pared to about half that in the Europeans. While verbal abuse was
most commonly also associated with concomitant physical or sex-
ual abuse, when we examined the reported occurrence of verbal
abuse alone, we  found it had major effects on both early onset and
a more adverse course of bipolar disorder of a magnitude similar
to the occurrence of physical or sexual abuse in childhood (Post
et al., 2015b). While verbal abuse is a soft indicator and subject
to a variety of recall biases, including individuals who are more
currently distressed viewing past interactions as more negative,
the data are consistent with other ﬁndings that bullying and other
forms of verbal abuse can have long lasting effects on psychopathol-
ogy (De Bellis and Zisk, 2014; Teicher and Samson, 2016; Wolke and
Lereya, 2015).
Other stressors occurring in the year prior to the onset of illness
and prior to the latest episode before joining the Network were
also greater in the US than in Europe. Stressors were lower and
remained relatively stable over the course of illness in the Euro-
peans (Post et al., 2013a). In contrast, stressors in the US were high
prior to illness onset and accumulated and increased further over
the course of illness (i.e., to the year prior to the last episode). These
stressors were in multiple domains, including loss of social support,
academic or employment difﬁculties, and ﬁnancial and health care
access problems.
A robust literature supports the viewpoint that a variety of
stressors in animals and man  can result in epigenetic changes,
many of which could have long term to life long consequences.
Epigenetic refers to “above genetics” and does not affect inherited
gene sequences, but in response to environmental stimuli, chem-
ical groups are placed on DNA or histones (around which DNA
is wrapped) or alter microRNA, which in turn alter how easily
genes are turned on and off or new proteins are made. We  have
reviewed the literature on the likely epigenetic basis of sensiti-
zation (or increased responsivity) to the recurrence of stressors,
affective episodes, and bouts of substance abuse that are associ-
ated with illness progression in the recurrent mood disorders (Post,
2016). Epigenetic mechanisms are conﬁrmed by the observations
that an inhibitor of DNA methylation (zebularine), can prevent the
long term effects of neonatal stress on levels of BDNF in frontal
cortex and prevent the development of behavioral sensitization to
repeated cocaine injections.
Epigenetic alterations can cross generations mediated by alter-
ations in maternal or paternal behavior (Meaney et al., 2013;
Weaver et al., 2004). In addition, a new mode of epigenetic trans-
generational transmission has been elucidated which conveys
alterations into the next generation in the absence of contact with
the parents (Bale, 2014; Post, 2016; Szutorisz et al., 2014). For
example, the offspring of an adult male rat that has experienced
stressors or self-administered drugs of abuse will have altered
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hat parent. It has been shown that some epigenetic marks con-
eyed in gametes (sperm or ova) escape erasure and are conveyed
o the next generation (Bale, 2014). Transmission to the next gen-
ration has also been shown to occur via double stranded RNA in
lood affecting sperm (Chen et al., 2016; Devanapally et al., 2015).
Thus transmission of transgenerational vulnerability could
otentially be conveyed by three different mechanisms: classical
enetics; epigenetics based on behavioral contact; and presumably
o a vastly lesser degree, gamete-mediated epigenetic transmis-
ion occurring in the absence of contact. Based on the available
ata, it would appear that those from the US would potentially
e more vulnerable to illness based on any or all three of these
echanisms (Post, 2016). These data would have important clini-
al implications, as they would suggest that the situation in the US
ould have consequences for future generations and is not likely to
e self-correcting.
.3. Cohort and anticipation effects add to the childhood onset
roblem
The pessimistic view of more genetic and epigenetic-based vul-
erability to illness of future generations in the US compared to the
uropeans is further bolstered by two
other time trends or secular phenomena; a cohort (year of birth)
ffect and an anticipation (generational) effect. The cohort effect
uggests that every birth cohort from the beginning of the 1900s has
ad an increased incidence and earlier age of onset of both unipolar
epression and bipolar disorder (Hirschfeld and Weissman, 2002;
essler et al., 2007; Lange and McInnis, 2002; Post et al., 2016b;
isscher et al., 2001). The mechanisms involved in the cohort effect,
hich has been demonstrated in many countries, are not known,
ut are likely multifactorial (Visscher et al., 2001). In addition, there
ay  also be cohort effects for ADHD and substance abuse (Kessler
t al., 2007), which could contribute to vulnerability in future gen-
rations.
The anticipation effect refers to the phenomena seen most
learly in neurological illnesses such as Huntington’s chorea (HC)
here the age of onset of illness may  be much earlier in the
ffspring than the parental generation. Both genetic (such as expan-
ion of triple repeat sequences in HC) and non-genetic mechanisms
f anticipation in bipolar disorder have been suggested.
Taken together these two different time trend or secular effects
n the general population further signal that the problems of early
nset unipolar and bipolar disorder may  be becoming more preva-
ent and problematic.
.4. Untoward results of inadequately treated bipolar disorder
This literature about the consequences of less-than-ideal treat-
ent has been reviewed in detail elsewhere (Post and Leverich,
008), but a few summary points are worthy of mention here. The
igh rates of dysfunction, disability, and suicide in bipolar disorder
re well known. Less well known are the effects of accumulating
umbers of episodes or duration of illness on cognitive dysfunction,
reatment refractoriness, loss of cortical volume, and develop-
ent of dementia in old age (Post et al., 2012). The estimates of
ears of premature loss of life expectancy of individuals with seri-
us psychiatric disorders is a staggering 1–3 decades depending
n an individuals residence in a speciﬁc state in the US (Colton
nd Manderscheid, 2006; Newcomer and Hennekens, 2007). This
egree of loss of life expectancy is based more on cardiovascular
isease than from suicide.vioral Reviews 74 (2017) 204–213 209
5. Clinical and public health implications and preliminary
recommendations
One way  of beginning to address the burgeoning problem of
childhood onset bipolar and related disorders is to begin to accept
the reality and magnitude of the problem. While the precise per-
centages of illness in the US compared to Europe may  vary across
studies and differ to some extent in subsequent replication studies,
the effects as reviewed here appear to be large, consistent across
multiple studies and methodologies, and internally consistent with
genetic and environmental vulnerability factors. Until this accep-
tance in the scientiﬁc and public community occurs, approaches
to the problems are likely to be desultory and inadequate. For
example, James et al. (2014) in examining hospitalization discharge
diagnoses in the US versus the United Kingdom found a 72.1 fold
increase for pediatric bipolar disorder and a 7.2 fold increase for
adult bipolar disorder, as well as a 13.2 fold increase for ADHD.
They concluded that the differences in the rates of pediatric bipolar
disorder may  be due to differences in diagnostic practices.
While differences in diagnostic practices could account for some
of the differences in hospitalization rates, they do not address the
phenomenally huge degrees of psychiatric morbidity that these
numbers represent. The rate of 100.9 hospitalizations per 100,000
population for childhood onset bipolar disorder in the US compared
to 1.4/100,000 in England is astounding. That represents a lot of
very sick children being hospitalized in the US even if there are
some ambiguities about the diagnostic labeling.
In addition, in the study of James et al. (2014) differences in diag-
nostic practices for pediatric bipolar disorder would not account
for the 13.2 fold increases in discharge diagnoses for ADHD in
children or the 7.2 fold increases in adult bipolar disorder in the
US versus England. While the data reviewed here may  have some
confounds of diagnostic differences in the US versus Europe that
require further study, the number of hospitalizations for something
resembling pediatric bipolar disorder in the US is alarming. This is
especially true since the very large literature reviewed above indi-
cates that compared to adult onset (or even late adolescent onset),
childhood onset bipolar disorder represents a more severe illness
with a poorer outcome in adulthood.
When Banks et al. (2006) found that US compared to British
while males ages 55–74 had small but statistically signiﬁcantly
higher frequencies of most medical illnesses adjusted for all con-
founders, they did not mince words and concluded that “American
adults are less healthy than Europeans at all wealth levels.” The
differences in pediatric bipolar or bipolar-like admissions in the US
versus Britain are astoundingly large and merit recognition as such.
Despite the caveats about cultural differences in diagnostic prac-
tice, it would appear prudent to recognize the enormous burden,
and tentatively conclude that American children are very likely less
healthy than Europeans.
In addition, given the breath of the existent data from so
many different methodologies that we have reviewed (including
comparative studies, high risk offspring studies, clinical popula-
tions, prospective follow up studies, and epidemiological data that
includes BP-NOS), one would hope that a reﬂexive response of “we
need more data”, be replaced with “given the enormous magni-
tude of the problem and implications for the health, well being, and
longevity of current and future generations, we must take action.”
One might suggest a health education campaign as a good place
to start. McGorry and colleagues in Australia have made great
strides in the area of early recognition and treatment in those with
pre-psychotic symptoms or prodromal schizophrenia. This is note-
worthy from the multiple perspectives of destigmatization, public
and political buy in, health care access, community involvement
in clinical trials, and initial positive results with psychotherapeu-
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Amminger et al., 2015). If this kind of initiative can be done with
rodromal schizophrenia, it certainly could be with early onset
epression and bipolar disorder where the need is vastly greater
n terms of the less than 1% incidence of schizophrenia compared
o the 2–3% incidence of bipolar disorder and the 10 fold higher
ercent with depression.
One needs to develop other early recognition strategies. In this
irection one could better inform high risk groups (parents with a
istory of depression or bipolar disorder who have young children)
o be cognizant of their child’s mood and behavior, and if major
roblems emerge to seek help for their child. As we have seen from
he data above, the saying “ psychiatric illness runs in families”
ould be promulgated and acted upon as it is in so many other med-
cal illnesses. If the risk of psychiatric illness in one parent is added
o by illness in the other parent (Gottesman et al., 2010; Lapalme
t al., 1997; Nordsletten et al., 2016), and multigenerational his-
ories of psychiatric illness are also present (Post et al., 2015a,b,
016a; Weissman et al., 2006), additional vigilance about illness in
he offspring may  be indicated. Certainly these genetic/familial vul-
erabilities, in concert with the occurrence of childhood adversity
nd prodromal symptoms and syndromes, should further heighten
wareness (Post et al., 2013b). Efforts could be directed at the
ublic, pediatricians, and primary care physicians, as well as psy-
hiatrists who could be encouraged to ask about the health of their
dult patients’ children. If a child is highly symptomatic and other
esources are not available (which is all too common), these adult
sychiatrists could consider initiating treatment.
Advocacy groups should also be encouraged to teach their mem-
ers about the high risk status of children of parents with mood and
elated disorders and to endorse evaluation and treatment seek-
ng in instances of social and educational impairment, rather than
ather than the current typical mode of hoping the behaviors will be
elf correcting and just go away. Ghaemi et al. (2003) emphasize the
dmonition of “ﬁrst do no harm” in relationship to the use of antide-
ressants in bipolar depression, and many would extend this in
eneral to treatment of childhood onset bipolar disorder. However,
gnoring the treatment of severely ill and dysfunctional children
ith psychiatric illness would appear more related to stigma, and
n some ways would in fact represent doing harm. This educational
ffort could also extend to support groups and to peer specialists
ho have increasingly important roles in advocacy groups such as
he Depression and Bipolar Support Alliance (DBSA).
One action that parents could take immediately is to begin to
ongitudinally chart the severity of dysfunction associated with the
ommon symptoms of childhood psychiatric illness. A secure on-
ine rating device is available from the Child Network, which can
e accessed at www.bipolarnews.org, click on Child Network. After
 brief one time demographics questionnaire and a longer symp-
om check list, parents are sent an email reminder every Sunday to
rieﬂy rate the severity of symptoms of depression, anxiety, ADHD,
ppositional behavior, and mania and to list any psychosocial or
rug treatment.
Such weekly ratings can be printed out graphically and taken
o physicians in order to better visualize the course, severity, and
onsistency of symptoms in order to more easily evaluate the need
or treatment and treatment effectiveness, if any is initiated.
When patients and family members are aware of the numerical
alues of blood glucose, blood pressure, cholesterol, and weight,
ore effective approaches to diabetes and cardiovascular dis-
ase are facilitated, and well-being and longevity are accordingly
nhanced. Similarly, longitudinal numerical or graphic monitor-
ng of a child’s illness behaviors will facilitate earlier recognition
nd more effective treatment. A cogent demonstration of this is
eported by Kessing et al. (2013). They randomized youngsters with
 ﬁrst hospitalization for mania to 2 years of specialty clinic treat-
ent versus treatment as usual (TAU). Specialty clinic treatmentvioral Reviews 74 (2017) 204–213
included: post-hospital transition counseling; psycho-education;
symptom recognition and monitoring; psychotherapy; and phar-
macotherapy. Not only were there markedly fewer relapses initially
over the ﬁrst 2 years in the specialty clinic group, but these differ-
ences persisted and were magniﬁed over the subsequent 4 years
even though all patients had returned to TAU after 2 years.
These data together with a large number of controlled studies
showing superior effects of randomized psychotherapy/psycho-
education compared to TAU in children and adults with bipolar
disorder (Scott et al., 2007; Swartz and Swanson, 2014; Vallarino
et al., 2015) provide strong evidence for the beneﬁts of multi-modal
psychotherapeutic and pharmacological treatment. Moreover,
Miklowitz et al. (2013) found that family focused treatment (FFT)
was superior to treatment as usual (TAU) in children with a
diagnosis of depression, BP-NOS, or cyclothymia who  also had a
positive family history of bipolar disorder (in a parent or sibling).
FFT includes illness education, monitoring, therapy, and enhanced
within family communication. The effects of FFT on depressive,
anxious, and manic symptoms were largest in families with high-
est levels of expressed negative emotion. Nadkarni and Fristad
(2010) reported that therapy might be able to prevent the conver-
sion of depression to bipolar disorder in high risk children. Other
psychotherapeutic work with families has also proved effective
(Fristad et al., 2009; Pavuluri et al., 2004).
The NIMH could hold conferences about the most effective
way of changing attitudes and fostering new initiatives. Certainly,
increased attention to the sparse portfolio of treatment-related
studies is indicated (Post, 2009; Post and Kowatch, 2006). Spe-
cial initiatives to encourage study of these illnesses in childhood
should be fostered and funded. When such a national initiative was
enacted to foster and fund studies of schizophrenia many decades
ago, dramatic increases in treatment studies for that illness rapidly
followed. A similar program is now needed to reverse the ongoing
dearth of treatment studies of both childhood and adult bipolar and
related disorders.
A treatment effectiveness network to acquire systematic data
from children being treated in clinical practice, like that available
for oncology patients treated in clinical practice situations orga-
nized by the National Cancer Institute, could help to more rapidly
generate needed treatment and prevention data. The need for these
kinds of data is highlighted by the ﬁndings of Findling et al. (2007)
that divalproex sodium was  no more effective than placebo in pre-
venting dropout from the study for any reason in 56 youth with
BP-NOS or cyclothymia and the presence of one parent with bipolar
disorder. Interestingly, youth with a higher family loading discon-
tinued earlier than those with less family loading. These ﬁndings
of no signiﬁcant effect of divalproex, contrast with the positive
effects of family focused therapy in a similar group of at risk youth
(Miklowitz et al., 2013). Practical comparative clinical trials using
randomized open data could rapidly provide guidance about best
treatment strategies (Post and Kowatch, 2006).
Shonkoff and Garner (2012) have advocated for pediatricians to
become the primary guardians of children’s health. They emphasize
that toxic stress in childhood (verbal, physical, and sexual abuse or
neglect) is a major cause of both medical and psychiatric illnesses
in adulthood. Most children with psychiatric problems are seen by
pediatricians and other primary care physicians (Anderson et al.,
2015), so enhanced efforts in the training of these non-specialists
for adequate recognition, treatment, or referral is indicated.
Hudziak et al. (2014) have campaigned for increased attention to
child health and brain development. They suggest universal efforts
for encouraging exercise, mindfulness, music, and meditation (each
of which has demonstrated positive effects on brain structure or
function) in school-aged children. In those who  are at high risk or
who are already symptomatic, more intensive or specialized treat-
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Given the magnitude and consequences of the problems of
hild health involved, it appears that very broad and multifaceted
pproaches are needed to begin to reduce and prevent these preva-
ent illnesses in both high risk children and in children in the general
opulation in the US. Some possible ﬁrst approaches are outlined
ere, but more innovative, comprehensive, and long term clinical,
esearch, and public health strategies are also required.
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